Governors in states without their own exchanges admit they have no fallback option if the Supreme Court takes away subsidies from an estimated 8 million consumers.
States have no plan to deal with the fallout if millions of consumers lose their health insurance subsidies later this year, should the Supreme Court agree with opponents of the Affordable Care Act when they make their case next month.
Loss of premium subsidies was topic number one at this weekend’s meeting of the National Governors Association in Washington, D.C., where even Republican governors who opposed the ACA did not relish the prospect of hearing from angry constituents, who would suddenly be unable to afford their health coverage. Many admittd they had urged Congress to do something about it.
An estimated 8 million people could be negatively affected by King v. Burwell; oral arguments are scheduled for March 4, 2015. The case involves the drafting of the ACA, with plaintiffs asserting that only those consumers who live in states with their own exchanges can receive financial assistance. As it turned out, 34 states used the federal exchange, HealthCare.gov, and 87% of consumers who signed up for coverage through that exchange received a premium subsidy. Federal figures show the average subsidy is $268.
The ruling is not expected before late June.
Governors were quick to wash their hands of responsibility—even those who might aspire for higher office. “That responsibility doesn't fall in the hands of the states or the governors, it falls in the hands of the leaders right here in Washington," Wisconsin Gov. Scott Walker, who is contemplating a run for the Republican presidential nomination in 2016, told the Associated Press. He's one of the many Republican leaders who resisted efforts to create a state-based health insurance exchange.
Some thought that even if the court struck down subsidies in states without their own exchanges, the justices would give states some breathing room. Utah Gov. Gary Herbert, a Republican, predicted the chances of the Supreme Court striking down the subsidies are "maybe 50-50."
"My expectation is that they'll give us some time to adjust," Herbert said.
Republican Governor Nikki Haley of South Carolina told The Washington Post that her state was considering legislation to set up an exchange to protect more than 170,000 consumers who have premium subsidies.
Around the Web
Republican Governors worry about fate of Obamacare subsidies
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More